Simulations Plus Acquires DILIsym Services

Lancaster, California-based Simulations Plus, which develops pharmaceutical simulation and modeling software, has acquired DILIsym Services, a developer of drug-induced liver injury simulation software and related consulting services to the pharmaceutical industry. Simluations Plus said it will pay $10M in total, split between $5M up front plus earn out of up to an additional $5M over the next three years based on profitability of its new DILIsym Services division. Simulations Plus said it will iadd employees from DILIsym Services with the buy, boosting its staff from 68 people to 79. The company said it will add more than $3M in revenues in its upcoming fiscal year 2018 due to the acquisition.